JudyCBougheyMDFACS

PubMed

• Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
  Giacomo Montagna, Mary M Mrdutt, Susie X Sun, Callie Hlavin, Emilia J Diego, Stephanie M Wong, Andrea V Barrio, Astrid Botty van den Bruele, Neslihan Cabioglu, Varadan...> ;JAMA Oncology. 2024 Apr 25
• Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer.
  Jodi M Carter, David Zahrieh, Jason P Sinnwell, Roberto Salgado, Vera J Suman, David W Hillman, Krishna R Kalari, Fergus J Couch, James N Ingle, Maschenka Balkenhol, F...> ;NPJ Breast Cancer. 2024 Mar 29
• Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
  Elias, A., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry Kapla...> ;Clinical Cancer Research. 2024 Feb 16
• Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
  Puneet Singh, Doreen Agnese, Miral Amin, Andrea V Barrio, Astrid Botty Van den Bruele, Erin Burke, David N Danforth Jr, Frederick M Dirbas, Firas Eladoumikdachi, Olga ...> ;Annals of Surgical Oncology. 2024 Apr 1
• 2 citations
  Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
  Alkhatib, H., Conage-Pough, J., Roy Chowdhury, S., Shian, D., Zaid, D., Rubinstein, A., Sonnenblick, A., Peretz-Yablonsky, T., Granit, A., Carmon, E., Kohale, I., Wang...> ;Molecular Cancer. 2024 Jan 16
• 2 citations
  Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
  Bedrosian, I., Somerfield, M., Achatz, M., Boughey, J., Curigliano, G., Friedman, S., Kohlmann, W., Kurian, A., Laronga, C., Lynce, F., Norquist, B., Plichta, J., Rodr...> ;Journal of Clinical Oncology. 2024 Feb 10
• Identification of a Notch transcriptomic signature for breast cancer.
  Braune, E., Geist, F., Tang, X., Kalari, K., Wang, L., D'Assoro, A., Goetz, M., Kreis, J., Wang, K., Foukakis, T., Seshire, A., Wienke, D., Lendahl, U., Boughey, J., L...> ;Breast Cancer Research. 2024 Jan 3
• Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
  Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
• ASO Visual Abstract: Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
  Amy K Schulze, Tanya L Hoskin, Dan Moldoveanu, Jenna L Sturz, Judy C Boughey> ;Annals of Surgical Oncology. 2024 Feb 1
• ASO Visual Abstract: Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
  Kush R Lohani, Tanya L Hoskin, Courtney N Day, Saba Yasir, Judy C Boughey, Amy C Degnim> ;Annals of Surgical Oncology. 2024 Feb 1
• ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers.
  Kush R Lohani, Tanya L Hoskin, Courtney N Day, Saba Yasir, Judy C Boughey, Amy C Degnim> ;Annals of Surgical Oncology. 2024 Feb 1
• Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
  Amy K Schulze, Tanya L Hoskin, Dan Moldoveanu, Jenna L Sturz, Judy C Boughey> ;Annals of Surgical Oncology. 2024 Feb 1
• Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer.
  Dan Moldoveanu, Tanya L Hoskin, Courtney N Day, Amy K Schulze, Matthew P Goetz, Judy C Boughey> ;Breast Cancer Research and Treatment. 2024 Feb 1
• 1 citations
  Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
  Kush R Lohani, Tanya L Hoskin, Courtney N Day, Saba Yasir, Judy C Boughey, Amy C Degnim> ;Annals of Surgical Oncology. 2024 Feb 1
• Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer.
  Jessica A Steadman, Tanya L Hoskin, Christine Klassen, Judy C Boughey, Amy C Degnim, Mara A Piltin, Mary M Mrdutt, Jeffrey E Johnson, Tina J Hieken> ;Surgery. 2024 Mar 1
• Lasting Impacts of the COVID-19 Pandemic on Breast Cancer Diagnosis and Treatment in the United States.
  Jenna L Sturz, Judy C Boughey> ;Surgical Oncology Clinics of North America. 2023 Oct 1
• 3 citations
  Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
  Robert W Mutter, Sharmila Giri, Briant F Fruth, Nicholas B Remmes, Judy C Boughey, Christin A Harless, Kathryn J Ruddy, Lisa A McGee, Arslan Afzal, Robert W Gao, Dean ...> ;The Lancet. Oncology. 2023 Oct 1
• 2 citations
  Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial.
  Johnson, H., Lin, H., Shen, Y., Diego, E., Krishnamurthy, S., Yang, W., Smith, B., Valero, V., Lucci, A., Sun, S., Shaitelman, S., Mitchell, M., Boughey, J., White, R....> ;JAMA Network Open. 2023 Sep 5
• Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease.
  Arielle P Stafford, Tanya L Hoskin, Tina J Hieken, Stacy Sanders, Sandhya Pruthi, Judy Boughey, Amy Degnim> ;Journal of Telemedicine and Telecare. 2023 Aug 24
• 1 citations
  Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
  Lauren Lenz, Chris Neff, Cara Solimeno, Elizabeth S Cogan, Vandana G Abramson, Judy C Boughey, Carla Falkson, Matthew P Goetz, James M Ford, William J Gradishar, Rache...> ;Breast Cancer Research and Treatment. 2023 Nov 1
• ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the...
  Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait, Jennifer D Son, Kirsten K Edmiston, Constantine Godellas, Marie C Lee, Michael J Carr...> ;Annals of Surgical Oncology. 2023 Oct 1
• ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer.
  Dan Moldoveanu, Tanya L Hoskin, Courtney N Day, Amy K Schulze, Matthew P Goetz, Judy C Boughey> ;Annals of Surgical Oncology. 2023 Oct 1
• ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management.
  Dan Moldoveanu, Matthew P Goetz, Judy C Boughey> ;Annals of Surgical Oncology. 2023 Oct 1
• 2 citations
  Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer.
  Dan Moldoveanu, Tanya L Hoskin, Courtney N Day, Amy K Schulze, Matthew P Goetz, Judy C Boughey> ;Annals of Surgical Oncology. 2023 Oct 1
• Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.
  Joshi, U., Budhathoki, P., Gaire, S., Yadav, S., Shah, A., Adhikari, A., Choong, G., Couzi, R., Giridhar, K., Leon-Ferre, R., Boughey, J., Hieken, T., Mutter, R., Rudd...> ;Breast Cancer Research and Treatment. 2023 Jul 1
• Join now to see all

Journal Articles

• Association of Low Nodal Positivity Rate Among Patients with ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...  
  Henry M Kuerer, Judy C Boughey, Alison U Barron, E Shelley Hwang, JAMA
• The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial  
  Kelly K Hunt, Armando Giuliano, Judy C Boughey, Laurie Cuttino, Kari M Rosenkranz, Bruce Haffty, Annals of Surgical Oncology
• Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy  
  James W Jakub, Amy C Degnim, Tina J Hieken, Judy C Boughey, Annals of Surgical Oncology
• Predicting Non-Sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy  
  Judy C Boughey, Alison U Barron, Annals of Surgical Oncology
• Treatment Outcomes for Pleomorphic Lobular Carcinoma in Situ of the Breast  
  Judy C Boughey, Tina J Hieken, Annals of Surgical Oncology
• Join now to see all

Lectures

• Effect of Primary Breast Tumor Location on Axillary Nodal Positivity 
  Mayo School of Continuous Professional Development, Rochester, Minnesota - 11/7/2012
• ASCO 2018: Dr. Judy C. Boughey on Neoadjuvant Chemotherapy for Breast Cancer Patients 
  Rochester, MN - 10/28/2014
• Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective cl... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018